The Escherichia coli multidrug efflux pump protein AcrB has recently been cocrystallized with various substrates, suggesting that there is a phenylalanine-rich binding site around F178 and F615. We found that F610A was the point mutation that had the most significant impact on substrate MICs, while other targeted mutations, including conversion of phenylalanines 136, 178, 615, 617, and 628 to alanine, had smaller and more variable effects.
NMP is moderately active in reversing MDR in clinical isolates of E. coli and can partially restore fluoroquinolone susceptibility through inhibition of efflux pumps.
The region around amino acid Val-610 in YhiV appears to be involved in determining recognition and efficiency of export of a number of MDR efflux pump substrates. This single point mutation in the periplasmic loop of the pump can increase resistance to a given drug such as a fluoroquinolone while decreasing resistance to another one.
A possible explanation for the discrepancy between the MIC and real-time efflux assays was that sertraline is a weak inducer of marA and acrB, thereby reducing its initial antibacterial and sensitizing effects over time. The results indicate that sertraline may be useful as a model efflux pump inhibitor for in vitro short-term experiments in E. coli, but is unlikely to be clinically useful as a co-drug against Gram-negative bacteria.
Sirtuins are NAD+ dependent lysine deacylases involved in many
regulatory processes such as control of metabolic pathways, DNA repair and stress
response. Modulators of sirtuin activity are required as tools for uncovering the
biological function of these enzymes and as potential therapeutic agents. Systematic
discovery of such modulators is hampered by the lack of direct and continuous
activity assays. The present study describes a novel continuous assay based on the
increase of a fluorescence signal subsequent to sirtuin mediated removal of a
fluorescent acyl chain from a modified TNFα-derived peptide. This
substrate is well recognized by human sirtuins 1–6 and represents the
best sirtuin 2 substrate described so far with a kcat/KM-value
of 176 000 M−1s−1.
These extraordinary substrate properties allow the first determination of
Ki-values for the specific Sirt2 inhibitory peptide S2iL5
(600 nM) and for the quasi-universal sirtuin inhibitor peptide thioxo
myristoyl TNFα (80 nM).
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.